Safety and Efficacy Evaluation of LX111 Gene Therapy in nAMD Patients
Safety and Efficacy Evaluation of LX111 Gene Therapy in nAMD Patients
Recruiting · NCT07053358 · Registry updated 2026-03-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy Evaluation of LX111 Gene Therapy in nAMD Patients | Neovascular Age-related Macular Degeneration | Recruiting | Early phase 1 | 2026-03-10 | NCT07053358 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Innostellar Biotherapeutics Co.,Ltd | 9 |
| Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 141 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Shanghai | China | 4 |